Theralase Technologies Inc. V.TLT

BTD

[MuskieMan50]

I meant news release from June 11 not newsletter

[enriquesuave]

it doesn't sound like anything has changed.  20-25 patients early 2021,so very soon.  IMO  "Shawn Shirazi, PhD, Chief Executive Officer of Theralase®, stated, “It is exciting to see Theralase® clear another hurdle by treating the first patient in the US and move one step closer to achieving its next milestone of enrolling and treating twenty-five patients in

[MuskieMan50]

Fast Track Designation (“FTD”) was granted by the US Food and Drug Administration (“FDA”) to Theralase® in November 2020. In order to potentially qualify for Breakthrough Therapy Designation (“BTD”) the Company has been advised by the FDA, to provide clinical assessment data for the primary, secondary and tertiary objective for approximately 20-25 patients treated at the therapeutic dose

[Oilminerdeluxe]

Timelines will always be broken. One should not take those things too literally. Even though one wants them to be kept on time.